APELLIS PHARMACT.DL-0001 (1JK:F) Annual Income Statement ()
1JK:F Quarterly Financials ()
Frequently Asked Questions About APELLIS PHARMACT.DL-0001 (1JK:F) Stock
APELLIS PHARMACT.DL-0001's (1JK:F) last reported annual revenue was N/A.
APELLIS PHARMACT.DL-0001's (1JK:F) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
APELLIS PHARMACT.DL-0001's(1JK:F) is not profitable as of its last reported annual financials.
The net profit margin for APELLIS PHARMACT.DL-0001's(1JK:F) from its laster reported year is N/A
The return on equity (ROE) for APELLIS PHARMACT.DL-0001's(1JK:F) from its last reported annual financials is : -106.56%
The return on assets (ROA) for APELLIS PHARMACT.DL-0001's(1JK:F) from its last reported annual financials is : -16.23%
The return on invested capital (ROIC) for APELLIS PHARMACT.DL-0001's(1JK:F) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for APELLIS PHARMACT.DL-0001's(1JK:F) from its last reported annual financials is : 0.00%
The dividend yield for APELLIS PHARMACT.DL-0001's(1JK:F) from its laster reported year is 0.00%
APELLIS PHARMACT.DL-0001's(1JK:F) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 1JK:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
